Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...
The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...
Paddy Davitt rates Johannes Hoff Thorup’s impressive Norwich City, who, as Thorup rightly asserted, were short-changed by the manner of the final scoreline against Stoke City.
Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...
Josh Sargent scores a second-half double to spark Norwich City to a win over Stoke City that revives their play-off hopes.
Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...
The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...
Norwich City will look to keep their play-off hopes alive when they welcome Stoke City to Carrow Road on Saturday afternoon ...
Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...
Former Stoke City players have paid tribute to club legend George Eastham at a memorial service to celebrate his life.
8d
tom's Hardware on MSNTSMC and Intel rumors stoke Taiwanese fears of losing its 'Silicon Shield'When you buy through links on our articles, Future and its syndication partners may earn a commission.
Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results